Germany's DKLM 2026 congress on laboratory medicine convenes amid a healthcare crisis: despite spending 12.6% of GDP on healthcare (highest in EU), Germany has below-average life expectancy and high avoidable hospitalization rates. The newly passed cost-cutting BStabG law systematically reduces preventive investments, creating a fundamental contradiction with laboratory medicine's promise of early detection and disease prevention.